Experimental cancer drugs

There are many drugs that are being studied in the treatment of cancer.

Binding of anti-cancer drug gemcitabine-squalene to human serum albumin

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

0-9

• 17α-Ethynyl-3α-androstanediol

• 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone

• 5N-Bicalutamide

• 6-Diazo-5-oxo-L-norleucine

A

• 8-Azaguanine

• ABTL0812

• ADH-1

• AI-10-49

• AMG 319

• Abagovomab

• Abexinostat

• Abituzumab

• Acridine carboxamide

• Actinium-225

• Adavosertib

• Adecatumumab

• Adegramotide

• Adozelesin

• Afimoxifene

• Alacizumab pegol

• Aldoxorubicin

• Alkyl-lysophospholipids

• Allovectin-7

• Alpha-Amanitin

• Alvocidib

• Amatuximab

• Amonafide

• Anti-CD22 immunotoxin

• Apatinib

• Artemisinin

• Ascrinvacumab

• Asunercept

• Atiprimod

• Atrasentan

B

• BI 811283

• Bafetinib

• Bavituximab

• Bemcentinib

• Bempegaldesleukin

• Birabresib

• Bivatuzumab mertansine

• Brigatinib

• Brivanib alaninate

• Bropirimine

• Brostallicin

• Bryostatin

• Buparlisib

C

• C-1027

• CRLX101

• Camidanlumab tesirine

• Canertinib

• Cantuzumab mertansine

• Cediranib

• Cerdulatinib

• Chlorotoxin

• Cilengitide

• Cixutumumab

• Clevegen

• Cobimetinib

• Cofetuzumab pelidotin

• Combretastatin A-4

• Combretastatin A-4 phosphate

• Cryptolepine

D

• DHA-paclitaxel

• Dactolisib

• Demcizumab

• Depatuxizumab mafodotin

• Devimistat

• Dichloroacetic acid

• Dinaciclib

• Discodermolide

• Duligotuzumab

• Duocarmycin

• Durvalumab

• Dusigitumab

• Dz13

E

• EM-5854

• EPI-7386

• ERX-11

• Eflapegrastim

• Eftilagimod alpha

• Enoticumab

• Ensituximab

• Entolimod

• Entospletinib

• Epacadostat

• Erbulozole

• Erdafitinib

• Ethandrostate

• Ethidium bromide

• Evofosfamide

F

• Fenretinide

• Ferruginol

• Filanesib

• Fluoromedroxyprogesterone acetate

• Forodesine

• Futuximab

G

• GVAX

• Galunisertib

• Gandotinib

• Gedatolisib

• Glembatumumab vedotin

• Glesatinib

• Glufosfamide

H

• HAMLET (protein complex)

I

• IMM-101

• IRGD

• Ibrutinib

• Icrucumab

• Ieramilimab

• Imalumab

• Imetelstat

• Imexon

• Indolocarbazole

• Intetumumab

• Ipatasertib

• Iratumumab

• Irofulven

• Irosustat

• Istiratumab

J

• JQ1

K

• KP1019

L

• Laniquidar

• Larotrectinib

• Lexatumumab

• Lilotomab

• Linsitinib

• Loncastuximab tesirine

• Lorvotuzumab mertansine

• Lucitanib

• Luminespib

M

• MK-2206

• Mafosfamide

• Mapatumumab

• Margetuximab

• Marimastat

• Maytansinoid

• Melflufen

• Merestinib

• Mertansine

• Metapristone

• Milatuzumab

• Mitumomab

• Momelotinib

N

• NAMI-A

• NK012

• Navitoclax

• Neocarzinostatin

• Nesvacumab

O

• O6-Benzylguanine

• ONX-0801

• OSI-7904

• OX1001

• Obatoclax

• Oblimersen

• Ofranergene obadenovec

• Ombrabulin

• Onapristone

• Ontuxizumab

• Oprozomib

• Oregovomab

P

• PAC-1

• Paclitaxel trevatide

• Pacritinib

• Palytoxin

• Patritumab

• Pelareorep

• Phosphoinositide 3-kinase inhibitor

• Plinabulin

• Plitidepsin

• Polmacoxib

• Poziotinib

• Prexasertib

• Prinomastat

• Pritumumab

• Proxalutamide

Q

• Quisinostat

• Quizartinib

R

• RAPTA

• RO4929097

• Radium-223

• Radretumab

• Ralimetinib

• Rebeccamycin

• Rezvilutamide

• Rigosertib

• Rindopepimut

• Robatumumab

• Rociletinib

• Rovalpituzumab tesirine

• Ruthenium anti-cancer drugs

S

• Salinosporamide A

• Sapacitabine

• Sapanisertib

• Saracatinib

• Saridegib

• Semaxanib

• Seribantumab

• Seviteronel

• Sitravatinib

T

• TAS-108

• Tanespimycin

• Tarextumab

• Tariquidar

• Taselisib

• Tasquinimod

• Technetium (99mTc) votumumab

• Tesevatinib

• Tiazofurin

• Tigilanol tiglate

• Tilomisole

• Tirapazamine

• Tivantinib

• Tivozanib

• Toca 511 and Toca FC

• Tovetumab

• Triciribine

• Troxacitabine

U

• Ubenimex

• Umbralisib

• Urelumab

V

• Vadimezan

• Valspodar

• Vantictumab

• Vanucizumab

• Vatalanib

• Veliparib

• Vintafolide

• Volasertib

Z

• ZB716

• Zibotentan

• Zosuquidar

Experimental cancer drugs Resources
Latest articles Most recent articles Ongoing trials	Wikipedia